FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Conron

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Anatomy

Macrophages, Alveolar

Devices

Co-author Network

Publications

TOP 3
Prudence A Russell; Zoe Wainer; Marzena Walkiewicz; Gavin M Wright; Rochelle Wynne; Stephen A Barnett; Matthew Conron; Julian Gooi; Simon Knight; Danny Liew; Thomas John
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Zoe Wainer; Naveed Z Alam; Phillip Antippa; David Binns; Jason Callahan; Matthew Conron; Marissa G Daniels; Rodney J Hicks; Prudence A Russell; Benjamin Solomon; Gavin M Wright
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.
Prudence A Russell; Zoe Wainer; Matthew Conron; Marissa Daniels; Gavin M Wright; Richard A Williams
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Conron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Prudence A Russell; Zoe Wainer; Marzena Walkiewicz; Gavin M Wright; Rochelle Wynne; Stephen A Barnett; Matthew Conron; Julian Gooi; Simon Knight; Danny Liew; Thomas John
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(4):461-8.
2012: Zoe Wainer; Naveed Z Alam; Phillip Antippa; David Binns; Jason Callahan; Matthew Conron; Marissa G Daniels; Rodney J Hicks; Prudence A Russell; Benjamin Solomon; Gavin M Wright
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(11):1676-85.
2011: Prudence A Russell; Zoe Wainer; Matthew Conron; Marissa Daniels; Gavin M Wright; Richard A Williams
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1496-504.
2011: Genni M Newnham; Matthew Conron; Sueanne McLachlan; Alexander Dobrovic; Hongdo DO; Jason Li; Kenneth Opeskin; Natalie Thompson; Gavin M Wright; David M Thomas
Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.
BMC cancer 2011;11():93.
2011: Tin Q Nguyen; Andrius Kalade; Shyam Prasad; Paul Desmond; Gavin Wright; David Hart; Matthew Conron; Robert Y Chen
Endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of mediastinal lesions.
ANZ journal of surgery 2011;81(1-2):75-8.
2010: Daniel P Steinfort; Danny Liew; Matthew Conron; Anastasia F Hutchinson; Louis B Irving
Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(10):1564-70.
2010: Daniel P Steinfort; Matthew Conron; Alpha Tsui; Sant-Rayn Pasricha; William E P Renwick; Phillip Antippa; Louis B Irving
Endobronchial ultrasound-guided transbronchial needle aspiration for the evaluation of suspected lymphoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):804-9.
2009: Anne E Holland; Catherine J Hill; Matthew Conron; Prue Munro; Christine McDonald
Small changes in six-minute walk distance are important in diffuse parenchymal lung disease.
Respiratory medicine 2009;103(10):1430-5.
2008: Genni M Newnham; David M Thomas; Sue Anne McLachlan; Gavin Wright; Matthew Conron
Molecular profiling of non-small cell lung cancer: of what value in clinical practice?
Heart, lung & circulation 2008;17(6):451-62.
2006: Renee L Manser; Gavin Wright; Graham Byrnes; David Hart; Matthew Conron; Rob Carter; Sue-Anne McLachlan; Donald A Campbell
Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):217-29.
2006: Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobrovic
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.
BMC cancer 2006;6():295.
2003: Brian M J Foxwell; Evangelos Andreakos; Fionula Brennan; Eugene Eyo Akujuru; Clive Smith; Matthew Conron
Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
Annals of the rheumatic diseases 2003;62 Suppl 2():ii90-3.
2002: Matthew Conron; Evangelos Andreakos; P Pantelidis; Clive Smith; H L C Beynon; Roland M Dubois; Brian M J Foxwell
Nuclear factor-kappaB activation in alveolar macrophages requires IkappaB kinase-beta, but not nuclear factor-kappaB inducing kinase.
American journal of respiratory and critical care medicine 2002;165(7):996-1004.
2001: Matthew Conron; J Bondeson; P Pantelidis; H L C Beynon; Eugene Eyo Akujuru; R M duBois; Brian M J Foxwell
Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways.
American journal of respiratory cell and molecular biology 2001;25(2):141-9.
2000: Matthew Conron; H L C Beynon
Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2000;17(3):277-80.
2000: Matthew Conron; H L C Beynon
Churg-Strauss syndrome.
Thorax 2000;55(10):870-7.
2000: Matthew Conron; C Young; H L C Beynon
Calcium metabolism in sarcoidosis and its clinical implications.
Rheumatology (Oxford, England) 2000;39(7):707-13.